Medicare, Medicaid Coverage Of Obesity Drugs Would Add $40bn In Government Spending

 
• By Cathy Kelly
  
CMS may have underestimated the cost of covering obesity medications. (Shutterstock)

More from Drug Pricing

More from Market Access